fda 503a bulks list peptides bpc-157 just got voted in favor to be added to the Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! BPC 157 PASSED! Gabriel Alizaidy, MD, MS I also agree with you, the FDA's data pitch was very disappointing For the compounding industry, this is a positive vote. It does not immediately make FDA may take an important step toward opening the peptide floodgates this week The biggest regulatory moment for peptides in 2026 happens this week. On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee meets to vote on whether BPC 157, TB 500, KPV, MOTS c, DSIP HIMS is up nearly 8% after FDA advisers voted to recommend adding BPC 157 to the 503A Bulks List. A major win for the peptide market.

SKU: 40990138858 · From vanierexcavation.com